Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Augmentation of Umbilical Cord Blood Transplantation for Inherited Metabolic Diseases With Intrathecal Administration of Human Umbilical Cord Blood-Derived Oligodendrocyte-Like Cells

NCT02254863 is registered in ClinicalTrials.gov with Joanne Kurtzberg, MD as lead sponsor.

NCT NCT02254863
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02254863 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Augmentation of Umbilical Cord Blood Transplantation for Inherited Metabolic Diseases With Intrathecal Administration of Human Umbilical Cord Blood-Derived Oligodendrocyte-Like Cells
Lead sponsor
Joanne Kurtzberg, MD
Phase
Phase 1
Overall status
Recruiting
Start date
September 30, 2014
Completion date
October 31, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adrenoleukodystrophy, alpha-mannosidosis, batten disease, brain diseases, metabolic, inborn, leukodystrophy, globoid cell, leukodystrophy, metachromatic, mucopolysaccharidosis ii, neimann pick disease, pelizaeus-merzbacher disease, sandhoff disease, sanfilippo mucopolysaccharidoses, tay-sachs disease